Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
152 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The U.S. companion animal health market size is expected to reach USD 8.2 billion by 2026, according to a new report by Grand View Research, Inc., registering a 5.2% CAGR over the forecast period. Rising number of pet owners seeking better healthcare services, healthier quality foods, and high-end grooming and training services for their companion animals is a major driver for this market. According to the American Pet Products Association (National Pet Owners Survey), 85 million households in the U.S. own a pet, especially dogs, out of which 60.2 million own multiple pets. Moreover, high-income families amounted to approximately 60% of the total spending. In recent years, pet adoption has shown immense growth. This is primarily attributed to the fact that people are healthier and happier in the presence of pets, as found by the Human Animal Bond Research Initiative Foundation (HABRI). With rising adoption of companion animals and growing concern about their health, there comes a direct association of pet insurance. Presently, pet insurance accounts for a small segment in the insurance industry. According to the North American Pet Health Insurance Association (NAPHIA) in 2017, 2.07 million pet owners had insurance for the same, which is 16.8% more than in 2016. This is showing promising growth as people have started opting for pet health insurance for timely and better treatment. Groundbreaking technological advances are rapidly transforming the pet health industry. These expansions are producing exciting new potentials. Some of the key market players are Zoetis, Merck, Ceva Sante Animale, Boehringer Ingelheim GmbH, and Elanco, which account for a considerable share in the market owing to their broad product offerings. Companies are taking strategic initiatives in pet health, such as adoption of big data, wearable technologies to monitor pet health, and inclusion of stem cell therapy. Moreover, established players are focusing on expanding their portfolio. For instance, Elanco acquired Bayer AG's animal health business unit in August 2019. Further key findings from the study suggest: • Based on type, dogs held the dominant share due to increasing spending on pet care, specifically in developed regions • By product, the pharmaceuticals segment is expected to gain popularity in the coming years owing to growing demand to increase pet longevity and rising R&D activities. • On the basis of distribution channel, the ecommerce segment is anticipated to witness rapid growth over the forecast period due to increased convenience offered to pet owners • Veterinary hospitals and clinics held the dominant share in terms of end use, mainly due to growing demand for services such as clinical pathology, toxicology tests, and therapy • Vetiquinol S.A., Zoetis, Merck, Ceva Sante Animale, Boehringer Ingelheim GmbH, and Elanco are some of the major market participants due to their product offerings and strong regional presence • Companies are adopting various strategies to gain competitive advantage, such as new product development, partnerships, mergers and acquisitions, collaborations, and regional expansion.
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Product
1.1.3 Distribution Channel
1.1.4 End Use
1.1.5 Etimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 U.S. Companion Animal Health Market Outlook, 2014 - 2026 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
Chapter 3 U.S. Companion Animal Health Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis
3.4 Industry Value Chain Analysis
3.4.1 Cost Structure Analysis
3.4.2 Distribution Channel Analysis
3.4.3 User Perspective Analysis
3.5 Technology Overview
3.5.1 Technology Timeline Veterinary Orthopedics Changing Technology & Adoption
3.6 Regulatory Framework
3.6.1 Reimbursement Framework
3.6.2 Standards & Compliances In The U.S.
3.7 U.S. Companion Animal Health Market dynamics
3.7.1 Market Driver Analysis
3.7.2 Market Restraint Analysis
3.7.3 Industry Challenges
3.8 U.S. Companion Animal Health Market Analysis Tools
3.8.1 Industry Analysis: Poter's
3.8.2 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.4 Market Entry Strategies
Chapter 4 U.S. Companion Animal Health Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Market Participation Categorization
4.2 Vendor Landscape
4.2.1 List Of Key Distributors And Channel Partners
4.2.2 Key Customers
4.3 Opportunity Analysis
4.3.1 U.S. Companion Animal Health: Company Market Share Analysis
4.3.2 Public Companies
4.3.3 Private Companies
Chapter 5 U.S. Companion Animal Health Market: Animal Type Estimates & Trend Analysis
5.1 Animal Type Market Share Analysis, 2018 & 2026
5.2 Animal Type Dashboard
5.3 U.S. Companion Animal Health Market, by Animal Type, 2014 to 2026
5.4 Dogs
5.4.1 Dogs Market Estimates And Forecasts, 2014 - 2026 (USD Million)
5.5 Equine
5.5.1 Equine Market Estimates And Forecasts, 2014 - 2026 (USD Million)
5.6 Cats
5.6.1 Cats Market Estimates And Forecasts, 2014 - 2026 (USD Million)
5.7 Others
5.7.1 Other Companion Animals Market Estimates And Forecasts, 2014 - 2026 (USD Million)
Chapter 6 U.S. Companion Animal Health Market: Product Estimates & Trend Analysis
6.1 Product Market Share Analysis, 2018 & 2026
6.2 Product Dashboard
6.3 U.S. Companion Animal Health Market, by Product, 2014 to 2026
6.4 Vaccines
6.4.1 Vaccines Market Estimates And Forecasts, 2014 - 2026 (USD Million)
6.5 Pharmaceuticals
6.5.1 Pharmaceuticals Market Estimates And Forecasts, 2014 - 2026 (USD Million)
6.5.2 OTC
6.5.3 Prescription
6.6 Feed Additives
6.6.1 Feed Additives Market Estimates And Forecasts, 2014 - 2026 (USD Million)
6.7 Diagnostics
6.7.1 Diagnostics Market Estimates And Forecasts, 2014 - 2026 (USD Million)
6.8 Others
Chapter 7 U.S. Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis
7.1 Distribution Channel Market Share Analysis, 2018 & 2026
7.2 Distribution Channel Dashboard
7.3 U.S. Companion Animal Health Market By Distribution Channel 2014 To 2026
7.3.1 Retail
7.3.2 Retail Market Estimates And Forecasts, 2014 - 2026 (USD Million)
7.4 E-Commerce
7.4.1 E-Commerce Market Estimates And Forecasts, 2014 - 2026 (USD Million)
7.5 Hospital Pharmacies
7.5.1 Hospital Pharmacy Market Estimates And Forecasts, 2014 - 2026 (USD Million)
Chapter 8 U.S. Companion Animal Health Market: End-use Estimates & Trend Analysis
8.1 End-use Market Share Analysis, 2018 & 2026
8.2 End-use Dashboard
8.3 U.S. Companion Animal Health Market by End-use, 2014 to 2026
8.4 Point-of-care/In-house Testing
8.4.1 Point-Of-Care/In-House Testing Market Estimates And Forecasts, 2014 - 2026 (USD Million)
8.5 Veterinary Hospitals & Clinics
8.5.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2014 - 2026 (USD Million)
8.6 Others
8.6.1 Others Market Estimates And Forecasts, 2014 - 2026 (USD Million)
Chapter 9 Company Profiles
9.1 Merck Animal Health
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Ceva Sante Animale
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Vetiquinol S.A.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Zoetis
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Boehringer Ingelheim GmbH
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Bayer AG
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Elanco
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Virbac, Inc.
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Norbrook Inc.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Dechra Pharmaceuticals
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Patterson Companies, Inc.
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Vedco Inc.
9.12.1 Company Overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic Initiatives
9.13 MWI Animal Health
9.13.1 Company Overview
9.13.2 Financial Performance
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Covetrus
9.14.1 Company Overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic Initiatives
9.15 Ellevet Sciences
9.15.1 Company Overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.15.4 Strategic Initiatives
9.16 Nutramax Laboratories Veterinary Sciences, Inc.
9.16.1 Company Overview
9.16.2 Product Benchmarking
9.16.3 Strategic Initiatives
List of Tables Table 1 List of secondary sources Table 2 List of abbreviation Table 3 US companion animal drug approvals from 2016 to 2018 Table 4 Products in pipeline Table 5 Deals & strategic alliances in U.S. Companion Animal Health Table 6 List of Distributors Table 7 List of key emerging companies Table 8 U.S. companion animal health market, by type, 2014 - 2026 (USD Million) Table 9 U.S. Companion animal health market, by product, 2014 - 2026 (USD Million) Table 10 U.S. pharmaceuticals market, by type, 2014 - 2026 (USD Million) Table 11 U.S. companion animal health market, by distribution channel, 2014 - 2026 (USD Million) Table 12 U.S. companion animal health market, by end use, 2014 - 2026 (USD Million)
List of Figures Fig. 1 Market segmentation Fig. 2 Market research process Fig. 3 Data triangulation techniques Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value-chain-based sizing & forecasting Fig. 7 QFD modeling for market share assessment Fig. 8 Market formulation & validation Fig. 9 Commodity flow analysis Fig. 10 U.S. companion animal health market revenue, 2014 - 2026 (USD Million) Fig. 11 U.S. Companion animal health market snapshot Fig. 12 Companion animal health market revenue, 2014 - 2026 (USD Million) Fig. 13 Penetration & growth prospect mapping Fig. 14 Drug development process for companion animal segment Fig. 15 Companion animal health: Market influencing factors Fig. 16 Companion animal health: Market dynamics Fig. 17 U.S. companion animal health market dynamics Fig. 18 U.S. Companion Animal Health market driver impact Fig. 19 U.S. Pet ownership statistics by animal type Fig. 20 U.S. Pet ownership statistics till 2018 Fig. 21 U.S. Companion Animal Health market restraint impact Fig. 22 U.S. Companion Animal Health market: Porter's five forces analysis Fig. 23 SWOT Analysis, By Factor (Political & legal, economic and technological) Fig. 24 Market entry strategies Fig. 25 Market participant categorization Fig. 26 Company Market Share Analysis, 2018 (%) Fig. 27 Competitive dashboard analysis Fig. 28 Company market position analysis Fig. 29 U.S. companion animal health market: Animal type movement analysis Fig. 30 U.S. companion animal health market animal type dashboard Fig. 31 U.S. companion animal health market by animal type Fig. 32 U.S. Dogs market, 2014 - 2026 (USD Million) Fig. 33 U.S. Equine market, 2014 - 2026 (USD Million) Fig. 34 U.S. Cats market, 2014 - 2026 (USD Million) Fig. 35 U.S. other companion animals market, 2014 - 2026 (USD Million) Fig. 36 U.S. companion animal health market: Product movement analysis Fig. 37 U.S. companion animal health product dashboard Fig. 38 U.S. companion animal health Market, by Product, 2014 to 2026 Fig. 39 U.S. vaccines market, 2014 - 2026 (USD Million) Fig. 40 U.S. pharmaceuticals market, 2014 - 2026 (USD Million) Fig. 41 U.S. OTC drugs market, 2014 - 2026 (USD Million) Fig. 42 U.S. prescription drugs market, 2014 - 2026 (USD Million) Fig. 43 U.S. feed additives market, 2014 - 2026 (USD Million) Fig. 44 U.S. diagnostics market, 2014 - 2026 (USD Million) Fig. 45 U.S. others market, 2014 - 2026 (USD Million) Fig. 46 U.S. companion animal health market: Distribution channel movement analysis Fig. 47 U.S. companion animal health market distribution channel dashboard Fig. 48 U.S. Companion Animal Health Market by Distribution Channel 2014 to 2026 Fig. 49 U.S. retail market, 2014 - 2026 (USD Million) Fig. 50 U.S. e-commerce market, 2014 - 2026 (USD Million) Fig. 51 U.S. hospital pharmacy market, 2014 - 2026 (USD Million) Fig. 52 U.S. companion animal health market: End-use movement analysis Fig. 53 U.S. companion animal health market end-use dashboard Fig. 54 U.S. companion animal health Market by End-use, 2014 to 2026 Fig. 55 U.S. point-of-care/in-house testing market, 2014 - 2026 (USD Million) Fig. 56 U.S. veterinary hospitals & clinics market, 2014 - 2026 (USD Million) Fig. 57 U.S. others market, 2014 - 2026 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
